The changing role of radioiodine in the management of differentiated thyroid cancer

Seminars in Nuclear Medicine

Volumn 27, Issue 2, 1997, Pages 152-164

  Reynolds, J C ^a   Robbins, J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; LITHIUM CARBONATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; THALLIUM 201; THYROGLOBULIN; THYROTROPIN;

CANCER RECURRENCE; CANCER SCINTISCANNING; CLINICAL TRIAL; DOSIMETRY; DRUG CLEARANCE; DRUG UPTAKE; HUMAN; HYPOTHYROIDISM; REVIEW; THYROID CANCER; THYROIDECTOMY;

EID: 0030903336     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(97)80045-1     Document Type: Article

References (67)

1. Kaplan MM Thyroid Carcinoma Endocrinol Metab Clin North Am 19 1990 3
2. Burman KD Thyroid Cancer Endocrinol Metab Clin North Am 24 1995 4
3. Wondisford FE Radovick S Moates JM Isolation and characterization of human thyrotropin beta-subunit gene J Biol Chem 263 1988 12538 12542
4. Thotakura NR Desai RK Bates LG Biologic activity and metabolic clearance of a recombinant human thyrotropin in Chinese Hamster ovary cells Endocrinology 128 1991 341 348
5. Huber GK Fon P Concepcion ES Davies TF Recombinant human thyroid-stimulating hormone-Initial bioactivity assessment using human fetal thyroid cells J Clin Endocrinol Metab 72 1991 1328 1331
6. Cole ES Lee K Lauziere K Recombinant human thyroid stimulating hormone: development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma Biotechnology 11 1993 1014 1024
7. Braverman LE Pratt BM Ebner S Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the Rhesus monkey J Clin Endocrinol Metab 74 1992 1135 1139
8. Meier CA Braverman LE Ebner SA Diagnostic use of human recombinant thyrotropin in patients with thyroid carcinoma (phase I/II study) J Clin Endocrinol Metab 78 1994 181 196
9. Szkudlinski MW Thotakura NR Bucci R Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells. The role of sialylation and sulfation in TSH bioactivity Endocrinology 133 1993 1490 1503
10. Spencer CA Wang C-C Thyroglobulin Measurements: Techniques, Clinical Benefits, and Pitfalls Endocrinol Metab Clin North Am 24 1995 841 863
11. Nemec J Rohling S Zamrazil V Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers J Nucl Med 20 1979 92 97
12. Pacini F Lippi F Formica N Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels J Nucl Med 28 1987 1888 1891
13. Schlumberger M Tubiana M De Vathaire F Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma J Clin Endocrinol Metab 63 1986 960 967
14. Schlumberger M Arcangioli O Piekarski JD Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays J Nucl Med 29 1988 1790 1794
15. Pineda JD Lee T Ain K Iodine-131 Therapy for thyroid cancer patients with elevated thryoglobulin and negative scan J Clin Endocrinol Metab 80 1995 1488 1492
16. Rudavsky AZ Freeman LM Treatment of scan negative, thyroglobulin positive metastatic thyroid cancer using radioiodine I-131 and recombinant human thyroid stimulating hormone J Clin Endocrinol Metab 82 1997 11 14
17. Ozata M Suzuki S Miyamoto T Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer J Clin Endocrinol Metab 79 1994 98 105
18. Sherman SI Tielens ET Sostre S Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma J Clin Endocrinol Metab 78 1994 629 634
19. Rawson RW Rall JE Peacock W Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine J Clin Endocrinol 11 1951 1128 1142
20. Hurley JR Becker DV The use of radioiodine in the management of thyroid cancer Freeman LM Weissman HS Nuclear Medicine Annual 1983 Raven New York, NY 329 384
21. Jeevanram RK Shah DH Sharma SM Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients Nucl Med Biol 13 1986 277 279
22. Park HM Perkins OW Edmondson JW Influence of diagnostic radioiodines on the uptake of ablation iodine-131 Thyroid 4 1994 49 54
23. Kim CK Tse K San Pedro E Influence of various scanning doses on subsequent I-131 ablation of thyroid remnants J Nucl Med 35 1994 14
24. 131I as scanning agents and their effect on the outcome of radioablation therapy Thyroid 7 1997 277 280
25. 201T1 Scintigraphy in post operative detection of thyroid cancer; A comparative study with I-131 Radiology 136 1980 461 464
26. Varma V Reba R Comparative study of T1-201 and I-131 scintigraphy in postoperative metastatic thyroid carcinoma Raynard C Nuclear Medicine and Biology Proceedings 3rd World Congress of Nuclear Medicine and Biology vol 1 1982 Pergamon Paris, France 103 104
27. 201T1 scintigraphy in the evaluation of differentiated thyroid cancer Eur J Nucl Med 9 1984 261 264
28. Hoefnagel CA Delprat CC Marcuse HR Role of Thallium-201 total-body scintigraphy in follow up of thyroid cancer J Nucl Med 27 1986 1854 1857
29. Brendel AJ Guyot M Jeanot R Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma J Nucl Med 29 1988 1515 1520
30. Charkes DN Vitti RA Brooks K Thallium-201 SPECT increases detectability of thyroid cancer metastases J Nucl Med 31 1990 147 153
31. Ramanna L Waxman A Braunstein G Thallium-201 scintigraphy in differentiated thyroid cancer; comparison with radioiodine scintigraphy and serum thyroglobulin determinations J Nucl Med 32 1996 441 446
32. Dadparvar S Krishna L Brady LW The role of Iodine-131 and Thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma Cancer 71 1993 3767 3773
33. Yen T-C Lin HD Lee CH The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hurthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans Eur J Nucl Med 21 1994 980 983
34. Dadparvar S Chevres A Tulchinsky M Clinical utility of Technetium-99m Methoxyisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with Thallium-201 and Iodine-131 scintigraphy, and serum thyroglobulin quantitation Eur J Nucl Med 22 1995 1330 1338
35. Russo R Col A Cappaglig M 99mTc-Sestamibi scan in the follow-up of differentiated thyroid carcinoma Eur J Nucl Med 23 1996 55
36. (abstr) Meyer G Kleine U Tiling R Tc-99m-Sestamibi whole body scintigraphy: An useful tool in the follow-up of patients with differentiated thyroid carcinoma Eur J Nucl Med 23 1996 S5
37. Nemec J Nyvitova O Blazek T Positive thyroid cancer scintigraph using technetium-99m methoxyisobutylisonitrile Eur J Nucl Med 23 1996 69 71
38. Joensuu H Ahonen A Imaging of metastases of thyroid carcinoma with Fluorine-18 fluorodeoxyglucose J Nucl Med 28 1987 910 914
39. Sisson JC Ackerman RJ Meyer MA Uptake of 18 fluoro-2-deoxy-D-glucose by thyroid cancer: Implications for diagnosis and therapy J Clin Endo Med 77 1993 1090 1095
40. Blahd WH Khonsary SA Brown CV Thyroid cancer imaging with PET FDG J Nucl Med 34 1993 12
41. Scott CG Meier DA Dickinson CZ Cervical lymph node metastasis of thyroid papillary carcinoma imaged with Fluorine-18-FDG, Technetium-99m Pertechnetate and Iodine-131 Sodium Iodine J Nucl Med 36 1995 1843 1845
42. Fridrich L Messa C Landoni C PET/[F-18]FDG and I-131 scintigraphy in patients with thyroid carcinoma Eur J Nucl Med 21 1994 780
43. Feine U Lietzemayer R Hanke JP 18 FDG whole body PET in differentiated thyroid carcinoma: Flip flop in uptake patterns of 18-FDG and I-131 Nuklearmedizin 34 1995 127 134
44. Grunwald F Schomburg A Bender H Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer Eur J Nucl Med 23 1996 312 319
45. Baudin E Schlumberger M Lumbroso J Octreotide scintigraphy in patients with differentiated thyroid carcinoma: Contribution for patients with negative radioiodine scan J Clin Endocrinol Metab 81 1966 2541 2544
46. McNeil BJ Rutter CM Harbert JC Eckelman WC Neumann RD Nuclear Medicine: Diagnosis and Therapy Methods for Evaluating New Tests 1996 Thieme New York, NY 939 947
47. Maxon RH Smith HS Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer Endocrinol Metab Clinics North Am 19 1990 685 718
48. Maxon HR Angler EE Thomas SR Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients J Nucl Med 33 1992 1132 1136
49. Maxon HR Thomas SR Hertzberg VS Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer N Engl J Med 309 1983 937 941
50. O'Connell ME Flower MA Hinton PJ Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET Radiother Oncol 28 1993 16 26
51. Reynolds JC Percent I-131 uptake and post therapy I-131 scans: their role in the management of thyroid cancer Thyroid 7 1997 281 284
52. 131I-131) therapy. 1. The necessity for in vivo quantitation and dosimetry in the treatment of carcinoma of the thyroid Radiother Oncol 14 1989 35 41
53. Hurley JR Becker DV Treatment of Thyroid Carcinoma with Radioiodine Gottschalk A Hoffer PB Potchen EJ Diagnostic Nuclear Medicine 1989 Williams & Wilkins Baltimore 792 814
54. Quimby EH Feitelberg S Gross W Radioactive Nuclides in Medicine and Biology: Basic Physics and Instrumentation 1970 Lea & Febiger Philadelphia, PA 114
55. Arnstein NB Carey JE Spaulding SA Determination of Iodine-131 diagnostic dose for imaging metastatic thyroid cancer J Nucl Med 27 1986 1764 1769
56. Keating FR Albert A The metabolism of iodine in man as disclosed with the use of radioiodine Recent Prog Hormone Res 4 1949 429 481
57. 131 J Clin Invest 34 1955 1057 1072
58. Park S-G Reynolds JC Brucker-Davis F Iodine kinetics during I-131 scanning in patients with thyroid cancer: comparison of studies with recombinant human TSH (rhTSH) vs. hypothyroidism J Nucl Med 37 1996 15
59. Beierwaltes WH The treatment of thyroid carcinoma with radioactive iodine Semin Nucl Med 8 1978 79 94
60. Temple R Berman M Carlson HE The use of lithium in Graves' disease Mayo Clin Proc 47 1972 872 879
61. Gershengorn MC Izumi M Robbins J Use of lithium as an adjunct to radiodine therapy of thyroid carcinoma J Clin Endocrinol Metab 42 1976 105 111
62. Briere J Pousse G Darsy P The advantage of lithium in association with iodine 131 in the treatment of functioning metastasis of thyroid cancer Ann Endocrinol 35 1974 281 282
63. Rasmusson B Olsen K Rygard J Lithium as adjunct to I-131 therapy of thyroid carcinoma Acta Endocrinologica 74 1983 252(s)
64. Pons F Carrio I Estorch M Lithium as an adjuvant of Iodine-131 when treating patients with well-differentiated thyroid carcinoma Clin Nucl Med 12 1987 644 647
65. Movius EG Robbins J Pierce LR The value of lithium in radioiodine therapy of thyroid carcinoma Medeiros-Neto G Gaitan E Frontiers in Thyroidology 1986 Plenum New York, NY 1269 1272
66. (abstr) Koong S-S Movius EG Keenan AM The effect of lithium in radioiodine therapy of metastatic well differentiated thyroid carcinoma J Nucl Med 36 1995 15
67. Strauss LG Conti PS The applications of PET in clinical oncology J Nucl Med 32 1991 623 628